Is Zeltiq Aesthetics Inc (ZLTQ) A Good Stock To Buy?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Zeltiq Aesthetics Inc (ZLTQ)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Aisling Capital Dennis Purcell | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.67 | 10,000 | Officer | 10,000 | 2013-04-29 | Filing | |
| $4.69 | 5,000 | Officer | 5,000 | 2013-04-29 | Filing | |
| $5.00 | 685,000 | Large Shareholder | 6,033,233 | 2012-08-07 | Filing | |
| $5.00 | 685,000 | Large Shareholder, Director | 6,033,233 | 2012-08-07 | Filing | |
| $4.89 | 20,000 | Large Shareholder | 5,348,233 | 2012-08-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.77 | 10,000 | Officer, Director | 220,430 | 2017-03-13 | Filing | |
| $55.64 | 3,000 | Officer | 46,301 | 2017-02-21 | Filing | |
| $55.69 | 10,000 | Officer, Director | 247,800 | 2017-02-13 | Filing | |
| $41.72 | 10,000 | Officer, Director | 219,939 | 2017-01-13 | Filing | |
| $44.91 | 100 | Officer | 79,198 | 2017-01-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Fat Wars: Is Jim Chanos Short ZELTIQ Aesthetics Inc (ZLTQ)?
Since institutional investors have released their equity portfolios for the end of the second quarter, Insider Monkey has analyzed the latest 13F filings of some 750 investors in order to determine ...
Hedge Funds Hated These Healthcare Stocks in Q1
The healthcare sector is down by about 3.75% so far this year, after enjoying a lengthy bull run into the middle of 2015.
Zeltiq Aesthetics Inc (ZLTQ): Are Hedge Funds Right About This Stock?
Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the third quarter.
Elite Hedge Funds Make Big Moves In These 3 Healthcare Stocks
A Schedule 13G is a public filing that must be submitted with the SEC by every hedge fund manager or other investor who acquires ownership of more than 5% in a publicly-traded company.
Four Hot Biotechs Among The Day’s Big Winners
On a day when Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is deep in the red following the release of its third quarter earnings, four other biotech stocks are making strong gains.
Goldman Sachs And Hedge Funds See Big Things For These Small-caps
The recent pull back in the Russell 2000 index left it down about 10% on a year-to-date basis just before the start of this month.
Five Stock Picks From Hedge Fund Sophrosyne Capital
Sophrosyne Capital is a multi strategy hedge fund founded in 2005. The firm has about $200 million in assets under management and is based in New York, NY.
Esperion Therapeutics Inc (ESPR), Cempra Inc (CEMP), Zeltiq Aesthetics Inc (ZLTQ): Aisling Capital's Winning Plays in Small-Cap Healthcare Stocks
On Tuesday, Esperion Therapeutics Inc (NASDAQ:ESPR)'s stock closed the trading section as one of the market leaders, ending the day up by 29%.
Zeltiq Aesthetics Inc (ZLTQ), Five Prime Therapeutics Inc (FPRX): Point72’s Latest Bullish Moves
Steve Cohen’s Point72 Asset Management has made bullish moves into a pair of medical technology stocks.